Sermorelin (GHRH 1-29)

$98.98

Sermorelin is a synthetic research peptide studied as a growth hormone–releasing hormone (GHRH) analog, widely examined for its receptor-specific activity and peptide-mediated signaling behavior in controlled laboratory models.

SKU4300
StatusIn stock
Categories,

Sermorelin (GHRH 1–29) – Growth Hormone–Releasing Hormone Fragment

Compound Name: Sermorelin (GHRH 1–29)
Classification: Research Peptide – GHRH Fragment

Description:

Sermorelin is a synthetic peptide fragment consisting of the first 29 amino acids of the endogenous growth hormone–releasing hormone (GHRH) sequence. In controlled laboratory research environments, it is widely studied for its receptor-specific interactions, peptide-mediated signaling activity, and involvement in endocrine regulatory pathways. Researchers commonly utilize Sermorelin in biochemical and in-vitro model systems to investigate growth hormone–related signaling mechanisms, receptor-binding dynamics, and intracellular pathways associated with peptide-regulated endocrine function.

Disclaimer:

This product is intended for laboratory research use only (RUO).
Not for human consumption.

Additional information

Size

10 mg